Current opinion in infectious diseases
Antiviral therapies for respiratory syncytial virus infection: current expectations.
María Alvarez de Toledo, Jeanette I Taveras, Octavio Ramilo, Asuncion Mejias
Published: 202610.1097/QCO.0000000000001184
Abstract
PURPOSE OF REVIEW: Respiratory syncytial virus (RSV) remains a leading cause of bronchiolitis in infants and young children, of pneumonia in children under 5 years of age and is also associated with significant mobility and mortality in immunocomprom…
Preview only. Read the full abstract at the source